Table 2 Active management and additional interventions:% (n)
Direct blood loss measurement | Indirect blood loss measurement | p-valuea | |
|---|---|---|---|
(n = 450) | (n = 450) | ||
Uterotonics used for active management | |||
Oxytocinb | 100.0 (450) | 100.0 (450) | na |
Misoprostol | 0.9 (4) | 1.1 (5) | > 0.99 |
Carboprost | 0.7 (3) | 0.2 (1) | 0.37 |
Additional uterotonics for treatment | |||
Oxytocin | 43.1 (194) | 44.7 (201) | 0.69 |
Misoprostol | 11.8 (53) | 10.0 (45) | 0.45 |
Carboprost | 2.0 (9) | 1.8 (8) | > 0.99 |
Episiotomy performed | 98.9 (445) | 98.9 (445) | > 0.99 |
Manual removal of placenta performed | 0.4 (2) | 0.9 (4) | 0.69 |
Other surgical intervention performed | |||
Internal iliac ligation | 0.0 (0) | 0.2 (1) | > 0.99 |
Resuturing of episiotomy | 0.2 (1) | 0.0 (0) | > 0.99 |
Blood transfusion given | 0.2 (1) | 0.2 (1) | > 0.99 |
Intravenous fluids given for PPH treatment | 0.9 (4) | 1.3 (6) | 0.75 |